FDA Approved: SEVELAMER CARBONATE — Original Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

FDA approved Sevelamer carbonate (brand Renvela) via an original NDA to treat hyperphosphatemia in adults with chronic kidney disease on dialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Hyperphosphatemia

Drugs mentioned

• Renvela (sevelamer carbonate)

Snippet

ORIG AP for SEVELAMER CARBONATE (SEVELAMER CARBONATE)